OpenAlex konusu

Myeloproliferative Neoplasms: Diagnosis and Treatment

Bu sayfa OpenAlex konu etiketine göre çalışmaları ve o konuda görünen akademisyenleri listeler. YÖKSİS temel alan / yan dal değildir.

OpenAlex 1.600 eser 51 yazar konusu

Çalışmalar

1.600 eser

Real-World Outcomes of Ruxolitinib as Salvage Therapy in Steroid-Refractory Acute and Chronic Graft-Versus-Host Disease: A Multicenter Retrospective Observational Study from Turkey 2026
Introduction & Objective: Graft-versus-host disease (GVHD) is a major complication of allogeneic hematopoietic stem cell transplantation (allo-HSCT), with limited treatment options for steroid-resistant cases. Ruxolitinib, a JAK1/2 inhibitor, has shown promise in treating steroid-resistant acute (aGVHD), chronic (cGVH…
PEGylated Interferon-α Treatment in Polycythemia Vera and Essential Thrombocythemia: A Single Center, Real-Life Experience 2026
Özet henüz yok.
Do We Need A CML-Specific Bleeding Tool? Concerns About The Proposed BAT-CML 2026
Özet henüz yok.
Thrombotic Events and Overall Survival in BCR-ABL1 Negative Myeloproliferative Neoplasms: A Single-Center Analysis 2026
Aim: BCR-ABL1–negative myeloproliferative neoplasms (MPNs), including polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF), are clonal disorders characterized by increased myeloid proliferation. This study retrospectively evaluated the clinical, demographic, molecular, and survival c…
Pathology of Bone Marrow 2026
Özet henüz yok.
Kronik myeloid lösemi ve kronik lenfositik löseminin eşzamanlı görülmesi: Nadir bir olgu 2026
Bu çalışmanın amacı, son derece nadir görülen kronik miyeloid lösemi (KML) ve kronik lenfositik lösemi (KLL) birlikteliğini içeren bir olguyu sunmak ve doğru tanısal yaklaşım ile uygun tedavi stratejilerinin belirlenmesine katkıda bulunmaktır. Lökositoz nedeniyle polikliniğimize başvuran 55 yaşındaki kadın hastanın ba…
Impact of Bone Marrow Fibrosis on Disease Characteristics and Outcomes in Newly Diagnosed Multiple Myeloma Patients 2026
Özet henüz yok.
Impact of Systemic Inflammatory and Autoimmune Diseases on Outcomes in Patients with Myelodysplastic Syndrome and Chronic Myelomonocytic Leukemia 2026
Özet henüz yok.
Citrullinated Histone 3 as a Marker of NETosis at Opposite Ends of Hemostasis: Evidence From Thrombosis-Prone MPN and Bleeding-Prone Hemophilia 2026
BackgroundNeutrophil extracellular trap (NET) formation has emerged as a key driver of thrombosis in myeloproliferative neoplasms (MPNs). Its role in congenital bleeding disorders, however, remains unexplored.ObjectivesTo investigate circulating citrullinated histone H3 (cit-H3), a marker of NETosis, in thrombosis-pro…
Correction to: Tirofiban-induced lingual edema and thrombocytopenia during management of ischemic stroke: a case report 2026
Özet henüz yok.
Case Report: Steroid Responsive Pompe Like Inflammatory Myositis With Complete Recovery After Allogeneic HSCT 2026
The data that support the findings of this study are available on request from the corresponding author. The data are not publicly available due to privacy or ethical restrictions.
Basophilic Erythroblast Emerges as the Key Turning Point in Polycythemia Vera 2026
Abstract Polycythemia vera (PV) is a rare, chronic myeloproliferative neoplasm driven by the JAK2 V617F mutation and characterized by uncontrolled erythroid proliferation. Although the mutation arises in hematopoietic stem cells, the differentiation stage at which its transcriptional consequences first become biologic…

Akademisyenler

51 akademisyen